united healthcare glp-1 coverage weight loss health care GLP-1 Drugs: Essential insights for employers GLP-1 Medications for Weight Loss
Description
Our medical team will conduct a thorough evaluation to determine if this treatment is safe and appropriate for you
This personalization helps your provider choose the right medication so your injections deliver the results your body is genetically primed to achieve
Phase 2 data of retatrutide, a similar triple agonist developed by Eli Lilly, has shown a remarkable 24% weight loss after 48 wk of treatment, without reaching a plateau (1)
Rocca WA
Recent Findings SGLT2-i consistently lower office SBP/DBP (2.54.0/1.52.0 mmHg) and 24-hour ambulatory BP (3.8/1.8 mmHg)
